Comment on "The impact of drug eluting stents on the co-release of interleukin-6 in patients with stable angina". [PDF]
Daungsupawong H, Wiwanitkit V.
europepmc +1 more source
Drug-Coated Balloons Versus Drug-Eluting Stents for Large Vessel Coronary Artery Disease: A Meta-Analysis. [PDF]
Zeng J +5 more
europepmc +1 more source
Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents? [PDF]
Gherasie FA, Valentin C, Busnatu SS.
europepmc +1 more source
Dedicated drug-eluting stents versus bare-metal stents for vertebral artery origin stenosis: a real-world single-center experience. [PDF]
Sun X +5 more
europepmc +1 more source
Short dual antiplatelet therapy after PCI with Resolute Onyx drug-eluting stents in high bleeding risk patients: One-year outcomes from a South Asian cohort. [PDF]
Jariwala P +3 more
europepmc +1 more source
The euros and sense of stents: do we get value for money? [PDF]
Annemans, Lieven
core +1 more source
Durable versus biodegradable polymer drug-eluting stents in all-comers. [PDF]
Witzig T +6 more
europepmc +1 more source
Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in Chronic Kidney Disease (CKD Dragon-Registry). [PDF]
Januszek R +26 more
europepmc +1 more source
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial. [PDF]
Han JK +20 more
europepmc +1 more source

